Logo image of CVE-PR-B.CA

CENOVUS ENERGY INC - CVECN 4.38 PERP (CVE-PR-B.CA) Stock Fundamental Analysis

TSX:CVE-PR-B - CA15135U4063

23.45 CAD
-0.29 (-1.22%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

5

CVE-PR-B gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 215 industry peers in the Oil, Gas & Consumable Fuels industry. CVE-PR-B has an average financial health and profitability rating. CVE-PR-B is not valued too expensively and it also shows a decent growth rate. Finally CVE-PR-B also has an excellent dividend rating. These ratings would make CVE-PR-B suitable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CVE-PR-B had positive earnings in the past year.
In the past year CVE-PR-B had a positive cash flow from operations.
Of the past 5 years CVE-PR-B 4 years were profitable.
In the past 5 years CVE-PR-B always reported a positive cash flow from operatings.
CVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

With a decent Return On Assets value of 4.74%, CVE-PR-B is doing good in the industry, outperforming 75.96% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.01%, CVE-PR-B is in the better half of the industry, outperforming 62.98% of the companies in the same industry.
CVE-PR-B has a better Return On Invested Capital (6.17%) than 76.92% of its industry peers.
CVE-PR-B had an Average Return On Invested Capital over the past 3 years of 11.92%. This is above the industry average of 6.99%.
The 3 year average ROIC (11.92%) for CVE-PR-B is well above the current ROIC(6.17%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.74%
ROE 9.01%
ROIC 6.17%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE-PR-B.CA Yearly ROA, ROE, ROICCVE-PR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Profit Margin of CVE-PR-B (5.13%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CVE-PR-B has declined.
CVE-PR-B has a Operating Margin (7.37%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CVE-PR-B has grown nicely.
CVE-PR-B has a Gross Margin of 31.62%. This is comparable to the rest of the industry: CVE-PR-B outperforms 51.44% of its industry peers.
In the last couple of years the Gross Margin of CVE-PR-B has declined.
Industry RankSector Rank
OM 7.37%
PM (TTM) 5.13%
GM 31.62%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE-PR-B.CA Yearly Profit, Operating, Gross MarginsCVE-PR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

CVE-PR-B has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CVE-PR-B has less shares outstanding
CVE-PR-B has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CVE-PR-B is higher compared to a year ago.
CVE-PR-B.CA Yearly Shares OutstandingCVE-PR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE-PR-B.CA Yearly Total Debt VS Total AssetsCVE-PR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE-PR-B has an Altman-Z score of 2.45. This is not the best score and indicates that CVE-PR-B is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CVE-PR-B (2.45) is better than 73.56% of its industry peers.
The Debt to FCF ratio of CVE-PR-B is 3.52, which is a good value as it means it would take CVE-PR-B, 3.52 years of fcf income to pay off all of its debts.
CVE-PR-B has a Debt to FCF ratio of 3.52. This is amongst the best in the industry. CVE-PR-B outperforms 82.21% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that CVE-PR-B is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.34, CVE-PR-B is in line with its industry, outperforming 56.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.52
Altman-Z 2.45
ROIC/WACC0.78
WACC7.91%
CVE-PR-B.CA Yearly LT Debt VS Equity VS FCFCVE-PR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

CVE-PR-B has a Current Ratio of 1.32. This is a normal value and indicates that CVE-PR-B is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.32, CVE-PR-B is doing good in the industry, outperforming 69.23% of the companies in the same industry.
CVE-PR-B has a Quick Ratio of 1.32. This is a bad value and indicates that CVE-PR-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CVE-PR-B's Quick ratio of 0.78 is in line compared to the rest of the industry. CVE-PR-B outperforms 58.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.78
CVE-PR-B.CA Yearly Current Assets VS Current LiabilitesCVE-PR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The earnings per share for CVE-PR-B have decreased strongly by -43.82% in the last year.
Measured over the past years, CVE-PR-B shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.97% on average per year.
Looking at the last year, CVE-PR-B shows a decrease in Revenue. The Revenue has decreased by -7.82% in the last year.
The Revenue has been growing by 21.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-43.82%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-15.09%
Revenue 1Y (TTM)-7.82%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-17.24%

3.2 Future

Based on estimates for the next years, CVE-PR-B will show a very strong growth in Earnings Per Share. The EPS will grow by 23.27% on average per year.
The Revenue is expected to decrease by -5.65% on average over the next years.
EPS Next Y1.47%
EPS Next 2Y-1.08%
EPS Next 3Y15.87%
EPS Next 5Y23.27%
Revenue Next Year-10.98%
Revenue Next 2Y-8.25%
Revenue Next 3Y-5.65%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVE-PR-B.CA Yearly Revenue VS EstimatesCVE-PR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE-PR-B.CA Yearly EPS VS EstimatesCVE-PR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.63, the valuation of CVE-PR-B can be described as correct.
Based on the Price/Earnings ratio, CVE-PR-B is valued a bit cheaper than 61.06% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.84, CVE-PR-B is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.61, which indicates a correct valuation of CVE-PR-B.
CVE-PR-B's Price/Forward Earnings is on the same level as the industry average.
CVE-PR-B is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.63
Fwd PE 14.61
CVE-PR-B.CA Price Earnings VS Forward Price EarningsCVE-PR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CVE-PR-B's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CVE-PR-B is cheaper than 81.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CVE-PR-B is valued a bit cheaper than the industry average as 66.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.18
EV/EBITDA 5.71
CVE-PR-B.CA Per share dataCVE-PR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CVE-PR-B does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CVE-PR-B may justify a higher PE ratio.
CVE-PR-B's earnings are expected to grow with 15.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.34
PEG (5Y)0.49
EPS Next 2Y-1.08%
EPS Next 3Y15.87%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.33%, CVE-PR-B is a good candidate for dividend investing.
CVE-PR-B's Dividend Yield is a higher than the industry average which is at 6.00.
Compared to an average S&P500 Dividend Yield of 2.32, CVE-PR-B pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.33%

5.2 History

The dividend of CVE-PR-B is nicely growing with an annual growth rate of 31.72%!
CVE-PR-B has been paying a dividend for at least 10 years, so it has a reliable track record.
CVE-PR-B has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)31.72%
Div Incr Years3
Div Non Decr Years3
CVE-PR-B.CA Yearly Dividends per shareCVE-PR-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CVE-PR-B pays out 52.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CVE-PR-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP52.38%
EPS Next 2Y-1.08%
EPS Next 3Y15.87%
CVE-PR-B.CA Yearly Income VS Free CF VS DividendCVE-PR-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE-PR-B.CA Dividend Payout.CVE-PR-B.CA Dividend Payout, showing the Payout Ratio.CVE-PR-B.CA Dividend Payout.PayoutRetained Earnings

CENOVUS ENERGY INC - CVECN 4.38 PERP

TSX:CVE-PR-B (9/2/2025, 7:00:00 PM)

23.45

-0.29 (-1.22%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners52.31%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap42.18B
Analysts79.09
Price Target30.47 (29.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.33%
Yearly Dividend0.84
Dividend Growth(5Y)31.72%
DP52.38%
Div Incr Years3
Div Non Decr Years3
Ex-Date09-15 2025-09-15 (0.27562)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)101.63%
Min EPS beat(2)25.67%
Max EPS beat(2)177.6%
EPS beat(4)2
Avg EPS beat(4)31.19%
Min EPS beat(4)-72.97%
Max EPS beat(4)177.6%
EPS beat(8)4
Avg EPS beat(8)15.06%
EPS beat(12)6
Avg EPS beat(12)3.89%
EPS beat(16)8
Avg EPS beat(16)-6.48%
Revenue beat(2)0
Avg Revenue beat(2)-4.79%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-4.15%
Revenue beat(4)1
Avg Revenue beat(4)-4.06%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)3.8%
Revenue beat(8)4
Avg Revenue beat(8)-0.2%
Revenue beat(12)6
Avg Revenue beat(12)3.13%
Revenue beat(16)10
Avg Revenue beat(16)5.12%
PT rev (1m)0%
PT rev (3m)-16.7%
EPS NQ rev (1m)-11.01%
EPS NQ rev (3m)-30.25%
EPS NY rev (1m)-4.83%
EPS NY rev (3m)-4.83%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-9.48%
Revenue NY rev (1m)-2.2%
Revenue NY rev (3m)-2.2%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 14.61
P/S 0.82
P/FCF 14.18
P/OCF 5.15
P/B 1.43
P/tB 1.59
EV/EBITDA 5.71
EPS(TTM)1.41
EY6.01%
EPS(NY)1.6
Fwd EY6.84%
FCF(TTM)1.65
FCFY7.05%
OCF(TTM)4.55
OCFY19.42%
SpS28.7
BVpS16.35
TBVpS14.72
PEG (NY)11.34
PEG (5Y)0.49
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 9.01%
ROCE 7.82%
ROIC 6.17%
ROICexc 6.51%
ROICexgc 6.95%
OM 7.37%
PM (TTM) 5.13%
GM 31.62%
FCFM 5.76%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexcg growth 3Y-0.51%
ROICexcg growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.52
Debt/EBITDA 1.14
Cap/Depr 105.59%
Cap/Sales 10.11%
Interest Coverage 250
Cash Conversion 93.66%
Profit Quality 112.35%
Current Ratio 1.32
Quick Ratio 0.78
Altman-Z 2.45
F-Score4
WACC7.91%
ROIC/WACC0.78
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.82%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-15.09%
EPS Next Y1.47%
EPS Next 2Y-1.08%
EPS Next 3Y15.87%
EPS Next 5Y23.27%
Revenue 1Y (TTM)-7.82%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-17.24%
Revenue Next Year-10.98%
Revenue Next 2Y-8.25%
Revenue Next 3Y-5.65%
Revenue Next 5YN/A
EBIT growth 1Y-45.73%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year96.04%
EBIT Next 3Y23.1%
EBIT Next 5Y17.51%
FCF growth 1Y-34.2%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y-6.52%
OCF growth 3Y15.98%
OCF growth 5Y22.96%